MedPath

Diphenhydramine

Generic Name
Diphenhydramine
Brand Names
Acetadryl, Advil PM, Aleve PM, Allegra Cooling Relief Anti-itch, Banophen, Benadryl, Benadryl Itch Stopping, Benadryl-D Allergy and Sinus, Calagel, Damylin With Codeine, Dimetapp Nighttime Cold & Congestion, Diphen, Diphenhist, Diphenist, Excedrin PM Triple Action, Goody's PM, Legatrin PM, Motrin PM, Nytol, Nytol Quickgels, Percogesic Reformulated Jan 2011, Siladryl, Simply Sleep, Sleepinal, Sominex, Triaminic Night Time Cold & Cough, Tylenol PM, Unisom, Unisom Sleep, Vanamine, Wal-dryl, Wal-som (doxylamine), Zzzquil
Drug Type
Small Molecule
Chemical Formula
C17H21NO
CAS Number
58-73-1
Unique Ingredient Identifier
8GTS82S83M
Background

Diphenhydramine - perhaps known most commonly as its brand name formulation Benadryl - is a first-generation H1 receptor antihistamine that is used extensively for the treatment of seasonal allergies, insect bites and stings, and rashes . However, it also has antiemetic, antitussive, hypnotic, and antiparkinson properties . As histamine receptors exist both peripherally and in the central nervous system, diphenhydramine has been shown to cause sedation due to its competitive antagonism of histamine H1 receptors within the central nervous system . While its use in allergy therapy can sometimes fall out of favor due to its sedative effect, diphenhydramine has been repurposed for use within many non-prescription over-the-counter sleep aids and cough-and-cold medications that have been marketed for "night time" use .

Diphenhydramine is also used in combination with 8-chlorotheophylline as the anti-nausea drug Dimenhydrinate where it is utilized primarily for its antagonism of H1 histamine receptors within the vestibular system .

Diphenhydramine has also been shown to be implicated in a number of neurotransmitter systems that affect behaviour including dopamine, norepinephrine, serotonin, acetylcholine, and opioid . As a result, diphenhydramine is being investigated for its anxiolytic and anti-depressant properties.

Indication

Diphenhydramine is a first-generation histamine H1 receptor antagonist (H1 antihistamine) that is widely available as a non-prescription, over-the-counter (OTC) medication. As an OTC medication, diphenhydramine is typically formulated as tablets and creams indicated for use in treating sneezing, runny nose, itchy/watery eyes, itching of nose or throat, insomnia, pruritis, urticaria, insect bites/stings, allergic rashes, and nausea .

Additionally, when the use of oral diphenhydramine is impractical, there are also prescription-only formulations such as diphenhydramine injection products that are effective in adults and pediatric patients (other than premature infants and neonates) for:

i) the amelioration of allergic reactions to blood or plasma, in anaphylaxis as an adjunct to epinephrine and other standard measures after acute allergic reaction symptoms have been controlled, and for other uncomplicated allergic conditions of the immediate type when oral therapy is impossible or contraindicated ;

ii) the active treatment of motion sickness ; and

iii) use in parkinsonism when oral therapy is impossible or contraindicated, as follows: parkinsonism in the elderly who are unable to tolerate more potent agents; mild cases of parkinsonism in other age groups, and in other cases of parkinsonism in combination with centrally acting anticholinergic agents .

Associated Conditions
Allergic Reaction, Allergic Rhinitis (AR), Allergic cough, Allergy to Tree Pollen, Anaphylaxis, Angioedema, Common Cold, Conjunctival irritation, Cough, Cough Variant Asthma, Cough caused by Common Cold, Eye allergy, Fever, Insect Bites, Insect Stings, Insomnia, Irritative cough, Itching of the nose, Itching of the throat, Motion Sickness, Nasal Congestion, Oral Mucositis, Pain, Parkinsonian Syndromes, Productive cough, Pruritus, Rash, Rhinorrhoea, Sinus Congestion, Sinus headache, Skin Irritation, Sneezing, Sunburn, Symptoms of Acute Bronchitis Accompanied by Coughing, Upper respiratory tract hypersensitivity reaction, site unspecified, Urticaria, Cold or flu syndrome, Dermatographism, Dry cough, Watery itchy eyes
Associated Therapies
Airway secretion clearance therapy, Expectorant

Lidocaine Versus Diphenhydramine to Achieve Local Anesthesia for Laceration Repairs

Phase 3
Not yet recruiting
Conditions
Laceration of Skin
Interventions
First Posted Date
2025-04-04
Last Posted Date
2025-04-06
Lead Sponsor
Florida Atlantic University
Target Recruit Count
100
Registration Number
NCT06910241
Locations
🇺🇸

Bethesda Hospital East, Boynton Beach, Florida, United States

Study of Tislelizumab and Platinum-based Chemotherapy Combination With H1 Receptor Antagonist(Diphenhydramine)in Advanced and Metastatic Non-Small Cell Lung Cancer

Phase 3
Not yet recruiting
Conditions
Advanced and Metastatic NSCLC
Interventions
First Posted Date
2024-11-26
Last Posted Date
2024-12-16
Lead Sponsor
Tianjin Medical University Cancer Institute and Hospital
Target Recruit Count
430
Registration Number
NCT06704620
Locations
🇨🇳

Tianjin Medical University Cancer Institute and Hospital, Tianjin, China

Anticholinergics for Cervical Edema in Labor

Phase 2
Not yet recruiting
Conditions
Labor Dystocia
Interventions
Combination Product: Usual Care
First Posted Date
2024-11-25
Last Posted Date
2024-11-25
Lead Sponsor
The University of Texas Health Science Center, Houston
Target Recruit Count
200
Registration Number
NCT06702670
Locations
🇺🇸

The University of Texas Health Science Center at Houston, Houston, Texas, United States

A Study to Investigate Subcutaneous Isatuximab in Combination With Weekly Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma

First Posted Date
2024-04-10
Last Posted Date
2025-05-18
Lead Sponsor
Sanofi
Target Recruit Count
64
Registration Number
NCT06356571
Locations
🇺🇸

Smilow Cancer Center at Yale-New Haven- Site Number : 8400020, New Haven, Connecticut, United States

🇺🇸

Millennium Oncology- Site Number : 8400011, Pembroke Pines, Florida, United States

🇺🇸

BRCR Global- Site Number : 8400008, Plantation, Florida, United States

and more 7 locations

Diphenhydramine in Catheter Related Bladder Discomfort

Not Applicable
Conditions
Catheter Complications
Interventions
First Posted Date
2024-04-03
Last Posted Date
2024-04-03
Lead Sponsor
Cairo University
Target Recruit Count
104
Registration Number
NCT06345261
Locations
🇪🇬

Cairo university, Cairo, Egypt

Efficacy of Prophylactic Treatment of Oral Prochlorperazine for Acute Mountain Sickness

Phase 4
Completed
Conditions
Acute Mountain Sickness
AMS
Interventions
Other: Immediate descent from altitude.
First Posted Date
2024-03-15
Last Posted Date
2024-05-28
Lead Sponsor
CHRISTUS Health
Target Recruit Count
30
Registration Number
NCT06310642
Locations
🇺🇸

CHRISTUS Health-Texas A&M Spohn Emergency Medicine Residency, Corpus Christi, Texas, United States

Over-the-Counter Antihistamines & Heat Stress

Phase 4
Recruiting
Conditions
Sudomotor Sympathetic Dysfunction
Heat Illness
Allergic Rhinitis
Heat Injury
Interventions
First Posted Date
2024-01-22
Last Posted Date
2024-01-22
Lead Sponsor
Lakehead University
Target Recruit Count
16
Registration Number
NCT06217367
Locations
🇨🇦

Lakehead University C.J Sanders Fieldhouse, Thunder Bay, Ontario, Canada

A Phase I/II Study of Intraperitoneal Paclitaxel in Patients with Metastatic Appendiceal Adenocarcinoma

Phase 1
Recruiting
Conditions
Metastatic Appendiceal Adenocarcinoma
Intraperitoneal Paclitaxel
Interventions
First Posted Date
2024-01-16
Last Posted Date
2025-01-24
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
39
Registration Number
NCT06207305
Locations
🇺🇸

MD Anderson Cancer Center, Houston, Texas, United States

Intravenous Fluids in Pediatric Migraine

Not Applicable
Recruiting
Conditions
Migraine in Children
Migraine
Interventions
Other: 1/2 maintenance fluids
Other: bolus
First Posted Date
2023-12-26
Last Posted Date
2023-12-26
Lead Sponsor
Dayton Children's Hospital
Target Recruit Count
134
Registration Number
NCT06182098
Locations
🇺🇸

Dayton Children's Hosptial, Dayton, Ohio, United States

Intranasal Ketorolac Trial

Phase 2
Recruiting
Conditions
Headache, Migraine
Interventions
First Posted Date
2023-10-16
Last Posted Date
2024-07-24
Lead Sponsor
Washington University School of Medicine
Target Recruit Count
120
Registration Number
NCT06083571
Locations
🇺🇸

Washington University in St. Louis, Saint Louis, Missouri, United States

© Copyright 2025. All Rights Reserved by MedPath